Lung cancer and chronic obstructive pulmonary disease: The story goes on

Radiology

Volumn 261, Issue 3, 2011, Pages 688-691

  Carrozzi, Laura ^a,b   Viegi, Giovanni ^b,c  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; ALLERGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; DELAYED DIAGNOSIS; DISEASE ASSOCIATION; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; LUNG EMPHYSEMA; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 81555207976     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11111950     Document Type: Editorial

References (37)

1. Cohen BH. Is pulmonary dysfunction the common denominator for the multiple effects of cigarette smoking? Lancet 1978; 2(8098):1024-1027. (Pubitemid 9058889)
2. Cohen BH. Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am J Epidemiol 1980;112(2):274-288. (Pubitemid 10018966)
3. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease: a prospective, matched, controlled study. Ann Intern Med 1986;105(4):503-507. (Pubitemid 16003992)
4. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987; 106(4):512-518. (Pubitemid 17095034)
5. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis 1990; 141(3):613-617. (Pubitemid 20109147)
6. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007;30(5):993-1013. (Pubitemid 351194805)
7. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005; 60(7):570-575. (Pubitemid 40966211)
8. Turner MC, Chen Y, Krewski DE, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007;176(3):285-290. (Pubitemid 47195879)
9. Wang Q, Takashima S, Wang JC, Zheng LM, Sone S. Prevalence of emphysema in individuals who underwent screening CT for lung cancer in Nagano prefecture of Japan. Respiration 2001;68(4):352-356. (Pubitemid 32678995)
10. Madani A, De Maertelaer V, Zanen J, Gevenois PA. Pulmonary emphysema: radiation dose and section thickness at multidetector CT quantification - comparison with macroscopic and microscopic morphometry. Radiology 2007;243(1):250-257. (Pubitemid 46579717)
11. Gierada DS, Pilgram TK, Whiting BR, et al. Comparison of standard- and low-radiationdose CT for quantification of emphysema. AJR Am J Roentgenol 2007;188(1):42-47. (Pubitemid 46012488)
12. Omori H, Nakashima R, Otsuka N, et al. Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence, and correlation with smoking habits and pulmonary function in Japanese male subjects. Respirology 2006;11(2):205-210. (Pubitemid 43356902)
13. Gietema HA, Schilham AM, van Ginneken B, van Klaveren RJ, Lammers JW, Prokop M. Monitoring of smoking-induced emphysema with CT in a lung cancer screening setting: detection of real increase in extent of emphysema. Radiology 2007;244(3):890-897. (Pubitemid 47292102)
14. Camiciottoli G, Cavigli E, Grassi L, et al. Prevalence and correlates of pulmonary emphysema in smokers and former smokers: a densitometric study of participants in the ITALUNG trial. Eur Radiol 2009;19(1): 58-66.
15. de Torres JP, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007;132(6):1932-1938.
16. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008;178(7): 738-744.
17. Kishi K, Gurney JW, Schroeder DR, Scanlon PD, Swensen SJ, Jett JR. The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study. Eur Respir J 2002;19(6):1093-1098. (Pubitemid 34649624)
18. Ueda K, Jinbo M, Li TS, Yagi T, Suga K, Hamano K. Computed tomography-diagnosed emphysema, not airway obstruction, is associated with the prognostic outcome of earlystage lung cancer. Clin Cancer Res 2006; 12(22):6730-6736. (Pubitemid 44876842)
19. Calabrò E, Randi G, La Vecchia C, et al. Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. Eur Respir J 2010;35(1):146-151.
20. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009;34(2):380-386.
21. Gierada DS, Guniganti P, Newman BJ, et al. Quantitative CT assessment of emphysema and airways in relation to lung cancer risk. Radiology 2011;261(3):950-959.
22. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395-409.
23. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349(9064):1498- 1504. (Pubitemid 27216360)
24. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years'observations on male British doctors. BMJ 2004;328:1529-1533. (Pubitemid 38850306)
25. ERS guidelines since 2000. http://www.erseducation. org/pages/default. aspx?id=2428. Published 2004. Accessed September 21, 2011.
26. GOLD initiative. http://www.goldcopd.org/. Accessed September 21, 2011.
27. Year of the Lung. http://yearofthelung.org/1752-world-spirometry-day- events.htm. Accessed September 21, 2011.
28. Schlesinger RB, Lippmann M. Selective particle deposition and bronchogenic carcinoma . Environ Res 1978;15(3):424-431. (Pubitemid 8377178)
29. Moghaddam SJ, Li H, Cho SN, et al. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am J Respir Cell Mol Biol 2009;40(4): 443-453.
30. Houghton AM, Mouded M, Shapiro SD. Com mon origins of lung cancer and COPD. Nat Med 2008;14(10):1023-1024.
31. Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? a review of epidemiological studies. Allergy 2005;60(9):1098-1111. (Pubitemid 41153134)
32. Carrozzi L, Viegi G. Allergy and cancer: a biological and epidemiological rebus. Allergy 2005;60(9):1095-1097. (Pubitemid 41153133)
33. Lindelöf B, Granath F, Tengvall-Linder M, Ekbom A. Allergy and cancer. Allergy 2005; 60(9):1116-1120. (Pubitemid 41153136)
34. National Lung Screening Trial Research Team, Aberle DR, Berg CD, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258(1):243-253.
35. Sozzi G, Roz L, Conte D, et al. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study. Am J Respir Crit Care Med 2009;179(1):69-74.
36. Carozzi FM, Bisanzi S, Falini P, et al. Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: perspectives of integrated strategies for early diagnosis. Lung Cancer 2010;68(2):216-221.
37. Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst 2009;101(8):554-559.